These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4545315)

  • 21. [Characterization of porcine and human serum kallikrein using inhibition through protein-proteinase inhibitors].
    Wunderer G; Kummer K; Fritz H
    Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1646-50. PubMed ID: 4539798
    [No Abstract]   [Full Text] [Related]  

  • 22. [Kallikrein activation and kininogen level in rat venous and arterial blood in acute myocardial ischemia].
    Gomazkov OA; Komissarova NV; Bol'shakova LV; Shimkovich MV
    Biull Eksp Biol Med; 1973 Aug; 76(8):25-7. PubMed ID: 4544262
    [No Abstract]   [Full Text] [Related]  

  • 23. [Kallikreinogen determination in the plasma of various species].
    Lehmann B; Kühne H; Scheuch DW
    Z Med Lab Diagn; 1981; 22(6):354-5. PubMed ID: 6177115
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes in the kallikrein-kinin system in chronic hemodialysis patients].
    Jankova T; Nenov D
    Z Urol Nephrol; 1982 Feb; 75(2):81-4. PubMed ID: 6918181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semisynthetic arginine-15-aprotinin, an improved inhibitor for human plasma kallikrein.
    Tschesche H; Beckmann J; Mehlich A; Feldmann A; Wenzel HR; Scott CF; Colman RW
    Adv Exp Med Biol; 1989; 247B():15-21. PubMed ID: 2481943
    [No Abstract]   [Full Text] [Related]  

  • 26. [Characterization of shock sensitivity in experimental hemorrhagic shock (5,3 and 8,0 kPa) by determining kallikrein, kallikreinogen, non-specific proteases and inhibitor capacity of blood plasma].
    Kühne H; Lehmann B; Taucher M; Scheuch DW
    Z Med Lab Diagn; 1983; 24(3):123-8. PubMed ID: 6351457
    [No Abstract]   [Full Text] [Related]  

  • 27. Small molecule inhibitors of plasma kallikrein.
    Young WB; Rai R; Shrader WD; Burgess-Henry J; Hu H; Elrod KC; Sprengeler PA; Katz BA; Sukbuntherng J; Mordenti J
    Bioorg Med Chem Lett; 2006 Apr; 16(7):2034-6. PubMed ID: 16413183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cold promoted activation of factor VII. VI. Effect of inhibitors.
    Gjonnaess H
    Thromb Diath Haemorrh; 1973 Jun; 29(3):633-43. PubMed ID: 4543422
    [No Abstract]   [Full Text] [Related]  

  • 29. Specificity of potato kallikrein inhibitors for kallikreins.
    Moriya H; Hojima Y; Moriwaki C; Tajima T
    Experientia; 1970; 26(7):720-1. PubMed ID: 5310879
    [No Abstract]   [Full Text] [Related]  

  • 30. Partial purification of bovine plasma kallikrein activated by contact with glass.
    Nagasawa S; Horiuchi K; Yano M; Suzuki T
    J Biochem; 1967 Sep; 62(3):398-400. PubMed ID: 5588801
    [No Abstract]   [Full Text] [Related]  

  • 31. [Various components of the kinin system of blood in bronchial asthma].
    Daniliak IG; Kuznetsov VA; Beliakov NV; Guliaeva FE
    Ter Arkh; 1978; 50(12):60-2. PubMed ID: 217118
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blood kallikrein-kinin system of bronchial asthma patients before and after treatment with proteinase inhibitors].
    Iasnitskaia MIa; Veremeenko KN
    Ter Arkh; 1981; 53(4):63-7. PubMed ID: 6167007
    [No Abstract]   [Full Text] [Related]  

  • 33. [Study of components of the blood kinin system in bronchial asthma].
    Iasnitskaia MIa
    Vrach Delo; 1980 Jun; (6):87-9. PubMed ID: 6157251
    [No Abstract]   [Full Text] [Related]  

  • 34. [Method of estimating kininogenesis in blood plasma].
    Surovikina MS; Lapshina IM; Maslikova GV; Drozdova GA; Vasil'ev AN
    Biull Eksp Biol Med; 1983 May; 95(5):115-8. PubMed ID: 6552201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Kallikreinogen-kallikrein system in the blood serum of patients with enterocolitis].
    Iarovaia GA; Dotsenko VL; Kozhevnikova LT
    Ter Arkh; 1975; 47(12):62-5. PubMed ID: 1224330
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness of commercial polyvalent proteinase inhibitors. Use of gordox in vascular surgery].
    Iarovaia GA; Dotsenko VL; Agapova EI; Nezhludko AIa; Stepanian EP
    Vopr Med Khim; 1980; 26(6):837-43. PubMed ID: 6906095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of plasma kallikrein selective inhibitors.
    Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
    Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using activated clotting time to estimate intraoperative aprotinin concentration.
    Iwata Y; Okamura T; Zurakowski D; Jonas RA
    Perfusion; 2009 Nov; 24(6):397-400. PubMed ID: 20093334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of vibration on the activity of the plasma kallikrein-kinin system in the rat.
    Gáti T; Budavári I; Szombath D; Losonczy G
    Acta Physiol Acad Sci Hung; 1982; 60(4):213-8. PubMed ID: 6926659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Human serum kallikreinogen. Methods of determination and properties].
    Paskhina TS; Dotsenko VL; Blinnikova EI
    Biokhimiia; 1973; 38(2):420-3. PubMed ID: 4781634
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.